Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yutian Zou

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|April 15, 2020
Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple-negative breast cancerShaoquan Zheng, Yutian Zou, Xinhua Xie, et al.
Frontiers in Cell and Developmental Biology|June 3, 2022
Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast CancerYutian Zou, Jindong Xie, Wenwen Tian, et al.
Frontiers in Molecular Biosciences|May 23, 2022
Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast CancerJindong Xie, Wenwen Tian, Yuhui Tang, et al.
Cancer Metastasis Reviews|June 9, 2026
Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progressHanqi Zhang, Yaqing Qin, Hanzhi Chu, et al.
Journal of Cancer|July 31, 2025
The Dual Roles of Circular RNAs in Breast Cancer Distant Metastasis and Their Clinical ApplicationsQing Bao, Huan Zhang, Pangzhou Chen, et al.
Imeta|June 13, 2024
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategiesJindong Xie, Manqing Liu, Xinpei Deng, et al.
Cancer Letters|December 3, 2025
Copper orchestrates triple-negative breast cancer progression via the STEAP3-dependent CDK16-JAK1 activationFangfang Duan, Chao Zhang, Zichao Wu, et al.
Frontiers in Immunology|January 23, 2023
Advances in artificial intelligence to predict cancer immunotherapy efficacyJindong Xie, Xiyuan Luo, Xinpei Deng, et al.
Carcinogenesis|April 20, 2019
circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expressionYutian Zou, Shaoquan Zheng, Weikai Xiao, et al.
Journal of Advanced Research|September 21, 2025
Cancer stem cell plasticity in shaping drug resistance landscapes in prostate cancerXiaoyu Zhang, Xiaoqing Zhang, Qing Bao, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|April 15, 2020
Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple-negative breast cancerShaoquan Zheng, Yutian Zou, Xinhua Xie, et al.
Frontiers in Cell and Developmental Biology|June 3, 2022
Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast CancerYutian Zou, Jindong Xie, Wenwen Tian, et al.
Frontiers in Molecular Biosciences|May 23, 2022
Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast CancerJindong Xie, Wenwen Tian, Yuhui Tang, et al.
Cancer Metastasis Reviews|June 9, 2026
Antibody-drug conjugates in breast cancer brain and leptomeningeal metastases: mechanistic insights and therapeutic progressHanqi Zhang, Yaqing Qin, Hanzhi Chu, et al.
Journal of Cancer|July 31, 2025
The Dual Roles of Circular RNAs in Breast Cancer Distant Metastasis and Their Clinical ApplicationsQing Bao, Huan Zhang, Pangzhou Chen, et al.
Imeta|June 13, 2024
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategiesJindong Xie, Manqing Liu, Xinpei Deng, et al.
Cancer Letters|December 3, 2025
Copper orchestrates triple-negative breast cancer progression via the STEAP3-dependent CDK16-JAK1 activationFangfang Duan, Chao Zhang, Zichao Wu, et al.
Frontiers in Immunology|January 23, 2023
Advances in artificial intelligence to predict cancer immunotherapy efficacyJindong Xie, Xiyuan Luo, Xinpei Deng, et al.
Carcinogenesis|April 20, 2019
circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expressionYutian Zou, Shaoquan Zheng, Weikai Xiao, et al.
Journal of Advanced Research|September 21, 2025
Cancer stem cell plasticity in shaping drug resistance landscapes in prostate cancerXiaoyu Zhang, Xiaoqing Zhang, Qing Bao, et al.
Pageof 8